nodes	percent_of_prediction	percent_of_DWPC	metapath
Montelukast—CYP2A6—Ifosfamide—testicular cancer	0.198	0.252	CbGbCtD
Montelukast—PTGS1—Ifosfamide—testicular cancer	0.169	0.215	CbGbCtD
Montelukast—CYP2C8—Ifosfamide—testicular cancer	0.0975	0.124	CbGbCtD
Montelukast—PTGS1—Etoposide—testicular cancer	0.0807	0.103	CbGbCtD
Montelukast—CYP2C9—Ifosfamide—testicular cancer	0.068	0.0866	CbGbCtD
Montelukast—CYP2C8—Etoposide—testicular cancer	0.0466	0.0594	CbGbCtD
Montelukast—CYP3A4—Ifosfamide—testicular cancer	0.0395	0.0504	CbGbCtD
Montelukast—CYP2C9—Cisplatin—testicular cancer	0.0331	0.0421	CbGbCtD
Montelukast—CYP3A4—Vinblastine—testicular cancer	0.021	0.0267	CbGbCtD
Montelukast—CYP3A4—Etoposide—testicular cancer	0.0189	0.0241	CbGbCtD
Montelukast—CYP3A4—Doxorubicin—testicular cancer	0.0129	0.0164	CbGbCtD
Montelukast—Unspecified disorder of skin and subcutaneous tissue—Etoposide—testicular cancer	0.0004	0.00185	CcSEcCtD
Montelukast—Gastrointestinal pain—Ifosfamide—testicular cancer	0.000399	0.00185	CcSEcCtD
Montelukast—Pancreatitis—Methotrexate—testicular cancer	0.000398	0.00185	CcSEcCtD
Montelukast—Toxic epidermal necrolysis—Epirubicin—testicular cancer	0.000396	0.00184	CcSEcCtD
Montelukast—Aspartate aminotransferase increased—Epirubicin—testicular cancer	0.000396	0.00184	CcSEcCtD
Montelukast—Nasopharyngitis—Epirubicin—testicular cancer	0.000393	0.00183	CcSEcCtD
Montelukast—Hypersensitivity—Dactinomycin—testicular cancer	0.000393	0.00182	CcSEcCtD
Montelukast—Alanine aminotransferase increased—Epirubicin—testicular cancer	0.000388	0.0018	CcSEcCtD
Montelukast—Urticaria—Ifosfamide—testicular cancer	0.000388	0.0018	CcSEcCtD
Montelukast—Abdominal pain—Ifosfamide—testicular cancer	0.000386	0.00179	CcSEcCtD
Montelukast—Body temperature increased—Ifosfamide—testicular cancer	0.000386	0.00179	CcSEcCtD
Montelukast—Anaphylactic shock—Etoposide—testicular cancer	0.000386	0.00179	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Cisplatin—testicular cancer	0.000384	0.00178	CcSEcCtD
Montelukast—Infection—Etoposide—testicular cancer	0.000383	0.00178	CcSEcCtD
Montelukast—Asthenia—Dactinomycin—testicular cancer	0.000382	0.00177	CcSEcCtD
Montelukast—Asthma—Epirubicin—testicular cancer	0.00038	0.00176	CcSEcCtD
Montelukast—Influenza—Epirubicin—testicular cancer	0.00038	0.00176	CcSEcCtD
Montelukast—Paraesthesia—Cisplatin—testicular cancer	0.000378	0.00175	CcSEcCtD
Montelukast—Thrombocytopenia—Etoposide—testicular cancer	0.000378	0.00175	CcSEcCtD
Montelukast—Upper respiratory tract infection—Methotrexate—testicular cancer	0.000378	0.00175	CcSEcCtD
Montelukast—Eosinophilia—Epirubicin—testicular cancer	0.000376	0.00175	CcSEcCtD
Montelukast—Skin disorder—Etoposide—testicular cancer	0.000375	0.00174	CcSEcCtD
Montelukast—Pancreatitis—Epirubicin—testicular cancer	0.000373	0.00173	CcSEcCtD
Montelukast—Toxic epidermal necrolysis—Doxorubicin—testicular cancer	0.000367	0.0017	CcSEcCtD
Montelukast—Aspartate aminotransferase increased—Doxorubicin—testicular cancer	0.000367	0.0017	CcSEcCtD
Montelukast—Bronchitis—Epirubicin—testicular cancer	0.000366	0.0017	CcSEcCtD
Montelukast—Diarrhoea—Dactinomycin—testicular cancer	0.000365	0.00169	CcSEcCtD
Montelukast—Pneumonia—Methotrexate—testicular cancer	0.000364	0.00169	CcSEcCtD
Montelukast—Nasopharyngitis—Doxorubicin—testicular cancer	0.000364	0.00169	CcSEcCtD
Montelukast—Gastrointestinal disorder—Cisplatin—testicular cancer	0.000363	0.00169	CcSEcCtD
Montelukast—Vomiting—Bleomycin—testicular cancer	0.000363	0.00169	CcSEcCtD
Montelukast—Infestation—Methotrexate—testicular cancer	0.000362	0.00168	CcSEcCtD
Montelukast—Infestation NOS—Methotrexate—testicular cancer	0.000362	0.00168	CcSEcCtD
Montelukast—Drowsiness—Methotrexate—testicular cancer	0.000362	0.00168	CcSEcCtD
Montelukast—Rash—Bleomycin—testicular cancer	0.00036	0.00167	CcSEcCtD
Montelukast—Pain—Cisplatin—testicular cancer	0.00036	0.00167	CcSEcCtD
Montelukast—Dermatitis—Bleomycin—testicular cancer	0.00036	0.00167	CcSEcCtD
Montelukast—Hypersensitivity—Ifosfamide—testicular cancer	0.00036	0.00167	CcSEcCtD
Montelukast—Stevens-Johnson syndrome—Methotrexate—testicular cancer	0.000359	0.00167	CcSEcCtD
Montelukast—Alanine aminotransferase increased—Doxorubicin—testicular cancer	0.000359	0.00167	CcSEcCtD
Montelukast—Upper respiratory tract infection—Epirubicin—testicular cancer	0.000353	0.00164	CcSEcCtD
Montelukast—Conjunctivitis—Methotrexate—testicular cancer	0.000352	0.00163	CcSEcCtD
Montelukast—Asthma—Doxorubicin—testicular cancer	0.000352	0.00163	CcSEcCtD
Montelukast—Influenza—Doxorubicin—testicular cancer	0.000352	0.00163	CcSEcCtD
Montelukast—Asthenia—Ifosfamide—testicular cancer	0.00035	0.00163	CcSEcCtD
Montelukast—Eosinophilia—Doxorubicin—testicular cancer	0.000348	0.00162	CcSEcCtD
Montelukast—Paraesthesia—Etoposide—testicular cancer	0.000346	0.00161	CcSEcCtD
Montelukast—Pruritus—Ifosfamide—testicular cancer	0.000345	0.0016	CcSEcCtD
Montelukast—Pancreatitis—Doxorubicin—testicular cancer	0.000345	0.0016	CcSEcCtD
Montelukast—Somnolence—Etoposide—testicular cancer	0.000343	0.00159	CcSEcCtD
Montelukast—Hepatobiliary disease—Methotrexate—testicular cancer	0.000343	0.00159	CcSEcCtD
Montelukast—Epistaxis—Methotrexate—testicular cancer	0.000342	0.00159	CcSEcCtD
Montelukast—Pneumonia—Epirubicin—testicular cancer	0.000341	0.00158	CcSEcCtD
Montelukast—Nausea—Bleomycin—testicular cancer	0.000339	0.00158	CcSEcCtD
Montelukast—Infestation NOS—Epirubicin—testicular cancer	0.000339	0.00157	CcSEcCtD
Montelukast—Infestation—Epirubicin—testicular cancer	0.000339	0.00157	CcSEcCtD
Montelukast—Drowsiness—Epirubicin—testicular cancer	0.000339	0.00157	CcSEcCtD
Montelukast—Vomiting—Dactinomycin—testicular cancer	0.000339	0.00157	CcSEcCtD
Montelukast—Bronchitis—Doxorubicin—testicular cancer	0.000338	0.00157	CcSEcCtD
Montelukast—Stevens-Johnson syndrome—Epirubicin—testicular cancer	0.000336	0.00156	CcSEcCtD
Montelukast—Rash—Dactinomycin—testicular cancer	0.000336	0.00156	CcSEcCtD
Montelukast—Diarrhoea—Ifosfamide—testicular cancer	0.000334	0.00155	CcSEcCtD
Montelukast—Gastrointestinal disorder—Etoposide—testicular cancer	0.000333	0.00155	CcSEcCtD
Montelukast—Body temperature increased—Cisplatin—testicular cancer	0.000333	0.00154	CcSEcCtD
Montelukast—Fatigue—Etoposide—testicular cancer	0.000333	0.00154	CcSEcCtD
Montelukast—Neuropathy peripheral—Epirubicin—testicular cancer	0.000332	0.00154	CcSEcCtD
Montelukast—Jaundice—Epirubicin—testicular cancer	0.00033	0.00153	CcSEcCtD
Montelukast—Pain—Etoposide—testicular cancer	0.00033	0.00153	CcSEcCtD
Montelukast—Conjunctivitis—Epirubicin—testicular cancer	0.000329	0.00153	CcSEcCtD
Montelukast—Upper respiratory tract infection—Doxorubicin—testicular cancer	0.000327	0.00152	CcSEcCtD
Montelukast—Hepatitis—Methotrexate—testicular cancer	0.000325	0.00151	CcSEcCtD
Montelukast—Dizziness—Ifosfamide—testicular cancer	0.000323	0.0015	CcSEcCtD
Montelukast—Pharyngitis—Methotrexate—testicular cancer	0.000323	0.0015	CcSEcCtD
Montelukast—Urinary tract disorder—Methotrexate—testicular cancer	0.000321	0.00149	CcSEcCtD
Montelukast—Hepatobiliary disease—Epirubicin—testicular cancer	0.000321	0.00149	CcSEcCtD
Montelukast—Epistaxis—Epirubicin—testicular cancer	0.00032	0.00148	CcSEcCtD
Montelukast—Urethral disorder—Methotrexate—testicular cancer	0.000319	0.00148	CcSEcCtD
Montelukast—Sinusitis—Epirubicin—testicular cancer	0.000318	0.00148	CcSEcCtD
Montelukast—Nausea—Dactinomycin—testicular cancer	0.000317	0.00147	CcSEcCtD
Montelukast—Pneumonia—Doxorubicin—testicular cancer	0.000315	0.00146	CcSEcCtD
Montelukast—Gastrointestinal pain—Etoposide—testicular cancer	0.000315	0.00146	CcSEcCtD
Montelukast—Infestation—Doxorubicin—testicular cancer	0.000314	0.00146	CcSEcCtD
Montelukast—Drowsiness—Doxorubicin—testicular cancer	0.000314	0.00146	CcSEcCtD
Montelukast—Infestation NOS—Doxorubicin—testicular cancer	0.000314	0.00146	CcSEcCtD
Montelukast—Stevens-Johnson syndrome—Doxorubicin—testicular cancer	0.000311	0.00144	CcSEcCtD
Montelukast—Vomiting—Ifosfamide—testicular cancer	0.00031	0.00144	CcSEcCtD
Montelukast—Hypersensitivity—Cisplatin—testicular cancer	0.00031	0.00144	CcSEcCtD
Montelukast—Rash—Ifosfamide—testicular cancer	0.000308	0.00143	CcSEcCtD
Montelukast—Dermatitis—Ifosfamide—testicular cancer	0.000308	0.00143	CcSEcCtD
Montelukast—Erythema multiforme—Methotrexate—testicular cancer	0.000307	0.00143	CcSEcCtD
Montelukast—Neuropathy peripheral—Doxorubicin—testicular cancer	0.000307	0.00143	CcSEcCtD
Montelukast—Urticaria—Etoposide—testicular cancer	0.000306	0.00142	CcSEcCtD
Montelukast—Jaundice—Doxorubicin—testicular cancer	0.000306	0.00142	CcSEcCtD
Montelukast—Rhinitis—Epirubicin—testicular cancer	0.000305	0.00142	CcSEcCtD
Montelukast—Abdominal pain—Etoposide—testicular cancer	0.000305	0.00142	CcSEcCtD
Montelukast—Body temperature increased—Etoposide—testicular cancer	0.000305	0.00142	CcSEcCtD
Montelukast—Conjunctivitis—Doxorubicin—testicular cancer	0.000305	0.00142	CcSEcCtD
Montelukast—Hepatitis—Epirubicin—testicular cancer	0.000304	0.00141	CcSEcCtD
Montelukast—Hypoaesthesia—Epirubicin—testicular cancer	0.000303	0.00141	CcSEcCtD
Montelukast—Asthenia—Cisplatin—testicular cancer	0.000302	0.0014	CcSEcCtD
Montelukast—Pharyngitis—Epirubicin—testicular cancer	0.000302	0.0014	CcSEcCtD
Montelukast—Cardiac disorder—Methotrexate—testicular cancer	0.000302	0.0014	CcSEcCtD
Montelukast—Urinary tract disorder—Epirubicin—testicular cancer	0.000301	0.00139	CcSEcCtD
Montelukast—Connective tissue disorder—Epirubicin—testicular cancer	0.000299	0.00139	CcSEcCtD
Montelukast—Urethral disorder—Epirubicin—testicular cancer	0.000298	0.00138	CcSEcCtD
Montelukast—Hepatobiliary disease—Doxorubicin—testicular cancer	0.000297	0.00138	CcSEcCtD
Montelukast—Epistaxis—Doxorubicin—testicular cancer	0.000296	0.00137	CcSEcCtD
Montelukast—Sinusitis—Doxorubicin—testicular cancer	0.000294	0.00137	CcSEcCtD
Montelukast—Immune system disorder—Methotrexate—testicular cancer	0.000294	0.00136	CcSEcCtD
Montelukast—Mediastinal disorder—Methotrexate—testicular cancer	0.000293	0.00136	CcSEcCtD
Montelukast—Nausea—Ifosfamide—testicular cancer	0.00029	0.00135	CcSEcCtD
Montelukast—Diarrhoea—Cisplatin—testicular cancer	0.000288	0.00134	CcSEcCtD
Montelukast—Erythema multiforme—Epirubicin—testicular cancer	0.000288	0.00134	CcSEcCtD
Montelukast—Mental disorder—Methotrexate—testicular cancer	0.000285	0.00132	CcSEcCtD
Montelukast—Hypersensitivity—Etoposide—testicular cancer	0.000284	0.00132	CcSEcCtD
Montelukast—Cardiac disorder—Epirubicin—testicular cancer	0.000282	0.00131	CcSEcCtD
Montelukast—Rhinitis—Doxorubicin—testicular cancer	0.000282	0.00131	CcSEcCtD
Montelukast—Hepatitis—Doxorubicin—testicular cancer	0.000282	0.00131	CcSEcCtD
Montelukast—Hypoaesthesia—Doxorubicin—testicular cancer	0.00028	0.0013	CcSEcCtD
Montelukast—Pharyngitis—Doxorubicin—testicular cancer	0.000279	0.0013	CcSEcCtD
Montelukast—Urinary tract disorder—Doxorubicin—testicular cancer	0.000278	0.00129	CcSEcCtD
Montelukast—Asthenia—Etoposide—testicular cancer	0.000277	0.00128	CcSEcCtD
Montelukast—Connective tissue disorder—Doxorubicin—testicular cancer	0.000277	0.00128	CcSEcCtD
Montelukast—Urethral disorder—Doxorubicin—testicular cancer	0.000276	0.00128	CcSEcCtD
Montelukast—Immune system disorder—Epirubicin—testicular cancer	0.000275	0.00128	CcSEcCtD
Montelukast—Mediastinal disorder—Epirubicin—testicular cancer	0.000274	0.00127	CcSEcCtD
Montelukast—Pruritus—Etoposide—testicular cancer	0.000273	0.00127	CcSEcCtD
Montelukast—Vomiting—Cisplatin—testicular cancer	0.000268	0.00124	CcSEcCtD
Montelukast—Mental disorder—Epirubicin—testicular cancer	0.000267	0.00124	CcSEcCtD
Montelukast—Erythema multiforme—Doxorubicin—testicular cancer	0.000266	0.00124	CcSEcCtD
Montelukast—Rash—Cisplatin—testicular cancer	0.000265	0.00123	CcSEcCtD
Montelukast—Dermatitis—Cisplatin—testicular cancer	0.000265	0.00123	CcSEcCtD
Montelukast—Diarrhoea—Etoposide—testicular cancer	0.000264	0.00122	CcSEcCtD
Montelukast—Cardiac disorder—Doxorubicin—testicular cancer	0.000261	0.00121	CcSEcCtD
Montelukast—Dizziness—Etoposide—testicular cancer	0.000255	0.00118	CcSEcCtD
Montelukast—Muscle spasms—Epirubicin—testicular cancer	0.000255	0.00118	CcSEcCtD
Montelukast—Immune system disorder—Doxorubicin—testicular cancer	0.000254	0.00118	CcSEcCtD
Montelukast—Mediastinal disorder—Doxorubicin—testicular cancer	0.000254	0.00118	CcSEcCtD
Montelukast—Nausea—Cisplatin—testicular cancer	0.00025	0.00116	CcSEcCtD
Montelukast—Cough—Methotrexate—testicular cancer	0.000247	0.00115	CcSEcCtD
Montelukast—Mental disorder—Doxorubicin—testicular cancer	0.000247	0.00114	CcSEcCtD
Montelukast—Convulsion—Methotrexate—testicular cancer	0.000245	0.00114	CcSEcCtD
Montelukast—Vomiting—Etoposide—testicular cancer	0.000245	0.00114	CcSEcCtD
Montelukast—Agitation—Epirubicin—testicular cancer	0.000243	0.00113	CcSEcCtD
Montelukast—Rash—Etoposide—testicular cancer	0.000243	0.00113	CcSEcCtD
Montelukast—Dermatitis—Etoposide—testicular cancer	0.000243	0.00113	CcSEcCtD
Montelukast—Headache—Etoposide—testicular cancer	0.000242	0.00112	CcSEcCtD
Montelukast—Myalgia—Methotrexate—testicular cancer	0.000241	0.00112	CcSEcCtD
Montelukast—Arthralgia—Methotrexate—testicular cancer	0.000241	0.00112	CcSEcCtD
Montelukast—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000239	0.00111	CcSEcCtD
Montelukast—Muscle spasms—Doxorubicin—testicular cancer	0.000236	0.00109	CcSEcCtD
Montelukast—Palpitations—Epirubicin—testicular cancer	0.000234	0.00109	CcSEcCtD
Montelukast—Cough—Epirubicin—testicular cancer	0.000231	0.00107	CcSEcCtD
Montelukast—Anaphylactic shock—Methotrexate—testicular cancer	0.000231	0.00107	CcSEcCtD
Montelukast—Convulsion—Epirubicin—testicular cancer	0.00023	0.00107	CcSEcCtD
Montelukast—Infection—Methotrexate—testicular cancer	0.00023	0.00107	CcSEcCtD
Montelukast—Nausea—Etoposide—testicular cancer	0.000229	0.00106	CcSEcCtD
Montelukast—Nervous system disorder—Methotrexate—testicular cancer	0.000227	0.00105	CcSEcCtD
Montelukast—Thrombocytopenia—Methotrexate—testicular cancer	0.000226	0.00105	CcSEcCtD
Montelukast—Myalgia—Epirubicin—testicular cancer	0.000226	0.00105	CcSEcCtD
Montelukast—Arthralgia—Epirubicin—testicular cancer	0.000226	0.00105	CcSEcCtD
Montelukast—Agitation—Doxorubicin—testicular cancer	0.000225	0.00105	CcSEcCtD
Montelukast—Anxiety—Epirubicin—testicular cancer	0.000225	0.00104	CcSEcCtD
Montelukast—Skin disorder—Methotrexate—testicular cancer	0.000224	0.00104	CcSEcCtD
Montelukast—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000224	0.00104	CcSEcCtD
Montelukast—Palpitations—Doxorubicin—testicular cancer	0.000217	0.00101	CcSEcCtD
Montelukast—Oedema—Epirubicin—testicular cancer	0.000216	0.001	CcSEcCtD
Montelukast—Anaphylactic shock—Epirubicin—testicular cancer	0.000216	0.001	CcSEcCtD
Montelukast—Infection—Epirubicin—testicular cancer	0.000215	0.000997	CcSEcCtD
Montelukast—Cough—Doxorubicin—testicular cancer	0.000214	0.000993	CcSEcCtD
Montelukast—Convulsion—Doxorubicin—testicular cancer	0.000212	0.000986	CcSEcCtD
Montelukast—Nervous system disorder—Epirubicin—testicular cancer	0.000212	0.000984	CcSEcCtD
Montelukast—Thrombocytopenia—Epirubicin—testicular cancer	0.000212	0.000983	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.00021	0.000977	CcSEcCtD
Montelukast—Skin disorder—Epirubicin—testicular cancer	0.00021	0.000975	CcSEcCtD
Montelukast—Insomnia—Methotrexate—testicular cancer	0.000209	0.00097	CcSEcCtD
Montelukast—Myalgia—Doxorubicin—testicular cancer	0.000209	0.000969	CcSEcCtD
Montelukast—Arthralgia—Doxorubicin—testicular cancer	0.000209	0.000969	CcSEcCtD
Montelukast—Anxiety—Doxorubicin—testicular cancer	0.000208	0.000965	CcSEcCtD
Montelukast—Paraesthesia—Methotrexate—testicular cancer	0.000207	0.000963	CcSEcCtD
Montelukast—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000207	0.000962	CcSEcCtD
Montelukast—Somnolence—Methotrexate—testicular cancer	0.000205	0.000953	CcSEcCtD
Montelukast—Dyspepsia—Methotrexate—testicular cancer	0.000203	0.000944	CcSEcCtD
Montelukast—Oedema—Doxorubicin—testicular cancer	0.0002	0.000928	CcSEcCtD
Montelukast—Anaphylactic shock—Doxorubicin—testicular cancer	0.0002	0.000928	CcSEcCtD
Montelukast—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000199	0.000926	CcSEcCtD
Montelukast—Fatigue—Methotrexate—testicular cancer	0.000199	0.000924	CcSEcCtD
Montelukast—Infection—Doxorubicin—testicular cancer	0.000199	0.000922	CcSEcCtD
Montelukast—Pain—Methotrexate—testicular cancer	0.000198	0.000917	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000197	0.000914	CcSEcCtD
Montelukast—Nervous system disorder—Doxorubicin—testicular cancer	0.000196	0.000911	CcSEcCtD
Montelukast—Thrombocytopenia—Doxorubicin—testicular cancer	0.000196	0.000909	CcSEcCtD
Montelukast—Insomnia—Epirubicin—testicular cancer	0.000196	0.000908	CcSEcCtD
Montelukast—Skin disorder—Doxorubicin—testicular cancer	0.000194	0.000902	CcSEcCtD
Montelukast—Paraesthesia—Epirubicin—testicular cancer	0.000194	0.000901	CcSEcCtD
Montelukast—Somnolence—Epirubicin—testicular cancer	0.000192	0.000892	CcSEcCtD
Montelukast—Dyspepsia—Epirubicin—testicular cancer	0.00019	0.000883	CcSEcCtD
Montelukast—Gastrointestinal pain—Methotrexate—testicular cancer	0.000189	0.000877	CcSEcCtD
Montelukast—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000187	0.000866	CcSEcCtD
Montelukast—Fatigue—Epirubicin—testicular cancer	0.000186	0.000865	CcSEcCtD
Montelukast—Pain—Epirubicin—testicular cancer	0.000185	0.000858	CcSEcCtD
Montelukast—Urticaria—Methotrexate—testicular cancer	0.000184	0.000852	CcSEcCtD
Montelukast—Abdominal pain—Methotrexate—testicular cancer	0.000183	0.000848	CcSEcCtD
Montelukast—Body temperature increased—Methotrexate—testicular cancer	0.000183	0.000848	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000182	0.000846	CcSEcCtD
Montelukast—Insomnia—Doxorubicin—testicular cancer	0.000181	0.00084	CcSEcCtD
Montelukast—Paraesthesia—Doxorubicin—testicular cancer	0.00018	0.000834	CcSEcCtD
Montelukast—Somnolence—Doxorubicin—testicular cancer	0.000178	0.000825	CcSEcCtD
Montelukast—Gastrointestinal pain—Epirubicin—testicular cancer	0.000177	0.000821	CcSEcCtD
Montelukast—Dyspepsia—Doxorubicin—testicular cancer	0.000176	0.000817	CcSEcCtD
Montelukast—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000173	0.000802	CcSEcCtD
Montelukast—Fatigue—Doxorubicin—testicular cancer	0.000172	0.000801	CcSEcCtD
Montelukast—Urticaria—Epirubicin—testicular cancer	0.000172	0.000797	CcSEcCtD
Montelukast—Pain—Doxorubicin—testicular cancer	0.000171	0.000794	CcSEcCtD
Montelukast—Body temperature increased—Epirubicin—testicular cancer	0.000171	0.000793	CcSEcCtD
Montelukast—Abdominal pain—Epirubicin—testicular cancer	0.000171	0.000793	CcSEcCtD
Montelukast—Hypersensitivity—Methotrexate—testicular cancer	0.00017	0.00079	CcSEcCtD
Montelukast—Asthenia—Methotrexate—testicular cancer	0.000166	0.000769	CcSEcCtD
Montelukast—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000164	0.000759	CcSEcCtD
Montelukast—Pruritus—Methotrexate—testicular cancer	0.000163	0.000759	CcSEcCtD
Montelukast—Hypersensitivity—Epirubicin—testicular cancer	0.000159	0.000739	CcSEcCtD
Montelukast—Urticaria—Doxorubicin—testicular cancer	0.000159	0.000738	CcSEcCtD
Montelukast—Abdominal pain—Doxorubicin—testicular cancer	0.000158	0.000734	CcSEcCtD
Montelukast—Body temperature increased—Doxorubicin—testicular cancer	0.000158	0.000734	CcSEcCtD
Montelukast—Diarrhoea—Methotrexate—testicular cancer	0.000158	0.000734	CcSEcCtD
Montelukast—Asthenia—Epirubicin—testicular cancer	0.000155	0.00072	CcSEcCtD
Montelukast—Pruritus—Epirubicin—testicular cancer	0.000153	0.00071	CcSEcCtD
Montelukast—Dizziness—Methotrexate—testicular cancer	0.000153	0.000709	CcSEcCtD
Montelukast—Diarrhoea—Epirubicin—testicular cancer	0.000148	0.000687	CcSEcCtD
Montelukast—Hypersensitivity—Doxorubicin—testicular cancer	0.000147	0.000684	CcSEcCtD
Montelukast—Vomiting—Methotrexate—testicular cancer	0.000147	0.000682	CcSEcCtD
Montelukast—Rash—Methotrexate—testicular cancer	0.000146	0.000676	CcSEcCtD
Montelukast—Dermatitis—Methotrexate—testicular cancer	0.000146	0.000675	CcSEcCtD
Montelukast—Headache—Methotrexate—testicular cancer	0.000145	0.000672	CcSEcCtD
Montelukast—Asthenia—Doxorubicin—testicular cancer	0.000144	0.000666	CcSEcCtD
Montelukast—Dizziness—Epirubicin—testicular cancer	0.000143	0.000664	CcSEcCtD
Montelukast—Pruritus—Doxorubicin—testicular cancer	0.000142	0.000657	CcSEcCtD
Montelukast—Vomiting—Epirubicin—testicular cancer	0.000137	0.000638	CcSEcCtD
Montelukast—Nausea—Methotrexate—testicular cancer	0.000137	0.000637	CcSEcCtD
Montelukast—Diarrhoea—Doxorubicin—testicular cancer	0.000137	0.000635	CcSEcCtD
Montelukast—Rash—Epirubicin—testicular cancer	0.000136	0.000633	CcSEcCtD
Montelukast—Dermatitis—Epirubicin—testicular cancer	0.000136	0.000632	CcSEcCtD
Montelukast—Headache—Epirubicin—testicular cancer	0.000135	0.000629	CcSEcCtD
Montelukast—Dizziness—Doxorubicin—testicular cancer	0.000132	0.000614	CcSEcCtD
Montelukast—Nausea—Epirubicin—testicular cancer	0.000128	0.000596	CcSEcCtD
Montelukast—Vomiting—Doxorubicin—testicular cancer	0.000127	0.00059	CcSEcCtD
Montelukast—Rash—Doxorubicin—testicular cancer	0.000126	0.000585	CcSEcCtD
Montelukast—Dermatitis—Doxorubicin—testicular cancer	0.000126	0.000585	CcSEcCtD
Montelukast—Headache—Doxorubicin—testicular cancer	0.000125	0.000582	CcSEcCtD
Montelukast—Nausea—Doxorubicin—testicular cancer	0.000119	0.000552	CcSEcCtD
